Pathological assessment of sentinel lymph-node biopsies in patients with breast cancer

Virchows Archiv

Volumn 436, Issue 2, 2000, Pages 97-101

  Lee, A H S ^a   Ellis, I O ^a   Pinder, S E ^a   Barbera, D ^a   Elston, C W ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYE;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LYMPH NODE BIOPSY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0034010137     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008220     Document Type: Review

References (59)

1. 1. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku NN, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822
2. 2. Axelsson CK, Mouridsen HT, Zedeler K (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 28A:1415-1418
3. 3. Ball ABS, Fish S, Waters R, Thomas JM (1992) Radical axillary dissection in the staging and treatment of breast cancer. Ann R Coll Surg Engl 74:126-129
4. 4. Boova RS, Bonanni R, Rosato FE (1982) Patterns of axillary nodal involvement in breast cancer. Ann Surg 196:642-644
5. 5. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S (1998) Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283
6. 6. Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Bruzzi P, Badellino F (1998) Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 24:104-109
7. 7. Clayton F, Hopkins CL (1993) Pathologic correlates of prognosis in lymph node positive breast carcinomas. Cancer 71: 1780-1790
8. 8. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645-653
9. 9. Cserni G (1999) Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work-up. J Clin Pathol 52:922-924
10. 10. Davies GC, Millis RR, Hayward JL (1980) Assessment of axillary lymph node status. Ann Surg 192:148-151
11. 11. De Mascarel I, Bonichon F, Coindre JM, Trojani M (1992) Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66:523-527
12. 12. Elston CW, Ellis IO (1998). The breast. (Systemic pathology, vol 13) Churchill Livingstone, Edinburgh
13. 13. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-772
14. 14. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. A NSABP update. Cancer 52:1551-1557
15. 15. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montague E, Margolese R, Foster R (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681
16. 16. Fisher CJ, Boyle S, Burke M, Price AB (1993) Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80:457-458
17. 17. Fisher ER, Palekar A, Rockette H, Redmond C, Fisher B (1978) Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro-and macrometastases. Cancer 42:2032-2038
18. 18. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, Contesso G (1988) Importance of tumor cells in axillary sinus margins ("clandestine" metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 27:483-487
19. 19. Galea MH, Blamey RW, Elston CE, Ellis IO (1992) The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22:207-219
20. 20. Galimberti V, Zurrida S, Zucali P, Luini A (1998) Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 7:8-10
21. 21. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401
22. 22. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401
23. 23. Giuliano A, Jones R, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350
24. 24. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K (1988) Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 14:407-412
25. 25. Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, McKenzie IFC, Bennett RC (1993) Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459-463
26. 26. Harris JR, Osteen RT (1985) Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5:17-21
27. 27. Hartveit F, Lilleng PK (1996) Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathology 28:241-246
28. 28. Huvos AG, Hutter RVP, Berg JW (1971) Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173:44-46
29. 29. International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568
30. 30. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136-138
31. 31. Kissen MW, Thompson EM, Price AB, Slavin G, Kark AE (1982) The inadequacy of axillary sampling in breast cancer. Lancet 1:1210-1212
32. 32. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P (1998) The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 339:941-946
33. 33. Kutiyanawala MA, Sayed M, Stotter A, Windle R, Rew D (1998) Staging the axilla in breast cancer: an audit of lymphnode retrieval in one UK regional centre. Eur J Surg Oncol 24: 280-282
34. 34. Mathiesen O, Carl J, Bonderup O, Panduro J (1990) Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol 29:721-725
35. 35. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG (1996) Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73:88-95
36. 36. McNeil C (1998) Sentinel node biopsy: studies should bring needed data. J Natl Cancer Inst 90:728-730
37. 37. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T (1998) Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 16:128-132
38. 38. Nasser IA, Lee AKC, Bosari S, Saganich R, Heatley G, Silverman ML (1993) Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 24:950-957
39. 39. National Coordinating Group for Breast Screening Pathology (1995) Pathology reporting in breast cancer screening. National Health Service Breast Screening Programme, Sheffield
40. 40. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H (1994) The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74: 1595-1600
41. 41. Nwariaku FE, Euhus DM, Beitsch PD, Clifford E, Erdman W, Mathews D, Albores-Saavedra J, Leitch MA, Peters GN (1998) Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg 176:529-531
42. 42. O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, Borgen PI, Cody HS (1998) Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186:423-427
43. 43. Recht A, Houlihan MJ (1995) Axillary lymph nodes and breast cancer. A review. Cancer 76:1491-1512
44. 44. Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW (1981) Axillary micro-and macrometastases in breast cancer. Ann Surg 194:585-591
45. 45. Rosen PP, Lesser ML, Kinne DW, Beattie EJ (1983) Discontinuous or "skip" metastases in breast carcinoma. Ann Surg 197:276-283
46. 46. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS (1998) Sentinel lymph node biopsy for staging breast cancer. Am J Surg 176:532-535
47. 47. Sacre RA (1986) Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12:169-173
48. 48. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC (1994) Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54:2986-2990
49. 49. Smith JA, Gamez-Araujo JJ, Gallagher HS, White EC, McBride CM (1977) Carcinoma of the breast. Analysis of total lymph node involvement versus level of metastasis. Cancer 39:527-532
50. 50. Snider H, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D (1998) Sentinel node biopsy in the staging of breast cancer. Am J Surg 176:305-310
51. 51. Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U (1985) The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 72:368-369
52. 52. Turner RR, Ollila DW, Stern S, Giuliano AE (1999) Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263-267
53. 53. Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, Meijer S (1999) Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 35:14-18
54. 54. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke R (1990) Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 16:127-133
55. 55. Veronesi U, Galimberti V, Zurrida S, Merson M, Greco M, Luini A (1993) Prognostic significance of number and level of axillary node metastases in breast cancer. Breast 2:224-228
56. 56. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 349:1864-1867
57. 57. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 91:368-373
58. 58. Weaver DL, Krag DN, Ashikaga T, Harlow SP (1999) Occult metastases in breast cancer are more likely to be detected in sentinel lymph nodes than in non-sentinel lymph nodes (abstract). Lab Invest 79:33A
59. 59. Wilkinson EJ, Hause LL, Hoffman RG, Kuzma JF, Rothwell DJ, Donegan WL, Clowry LJ, Almagro UA, Choi H, Rimm AA (1982) Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 17:67-91